SHARON LIOU: Open Payments
NPI 1477287936 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,515 in 76 payments from 23 companies in 2025. Trend: 2023 $137 · 2024 $2,955 · 2025 $2,515
Food & beverage: $2,515
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $435 |
| Novo Nordisk Inc | 11 | $336 |
| Lilly USA, LLC | 8 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $196 |
| ABBVIE INC. | 4 | $186 |
| ViiV Healthcare Company | 3 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $138 |
| Amgen Inc. | 1 | $132 |
| Intra-Sana Laboratories | 2 | $100 |
| Janssen Pharmaceuticals, Inc | 3 | $79 |
Products named: AIRSUPRA, MOUNJARO, APRETUDE, Ozempic, JARDIANCE, XIFAXAN, QULIPTA, RELTONE 200 MG.
Industry payments across CA — which companies pay providers there.
